Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
04/19/2000 | EP0788479B1 Substituted phthalimido-cinnamic acid derivatives with herbicidal effect |
04/19/2000 | CN1250768A Process for preparing anthracene, phenanthrene and karbazole |
04/19/2000 | CN1051551C Novel pyrrolocarbazoles derivatives |
04/19/2000 | CN1051452C Application of 3-substituted aryl oxidized indole compounds |
04/18/2000 | US6051719 Dibenzorhodamine dyes |
04/18/2000 | US6051610 Compounds useful as neuroprotectants, anticonvulsants, anxiolytics, analgesics, muscle relaxants or adjuvants to general anesthetics |
04/18/2000 | US6051593 3-(cycloalkanoheteroarylidenyl)-2- indolinone protein tyrosine kinase inhibitors |
04/18/2000 | US6051588 Which have significantly reduced gastrointestinal side effects |
04/18/2000 | US6051583 2,3,3a,4,9,9a-hexahydro-8-hydroxy-1H-benz[f]indoles, processes for preparing them and their use as pharmaceutical compositions |
04/18/2000 | US6051566 Anti-reactive anti-asthmatic activity of non-steroidal anti-inflammatory drugs by inhalation |
04/18/2000 | US6051561 Compounds and compositions for delivering active agents |
04/13/2000 | WO2000020388A1 Indolin derivatives as sun protection agents |
04/13/2000 | WO2000020382A1 Energetic nitramine-linked azoles and hydroxylammonium salts as oxidizers, initiators and gas generators |
04/13/2000 | WO2000020376A1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor |
04/13/2000 | WO2000002850A3 Sulfonylamino carboxylic acid n-arylamides as guanylate cyclase activators |
04/13/2000 | DE19842416A1 Sekundäre Amine zur Prävention und Therapie von Erkrankungen, die durch Oxidationsprozesse verursacht oder verstärkt werden Secondary amines for the prevention and treatment of diseases that are caused or aggravated by oxidation processes |
04/13/2000 | CA2346363A1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor |
04/12/2000 | EP0991645A1 Bis-indole derivatives having antimetastatic activity, a process for their preparation and pharmaceutical compositions containing them |
04/12/2000 | EP0991624A1 Phenylalkyl derivatives with thrombin-inhibiting effect |
04/12/2000 | EP0991623A2 Quinoline-indole antimicrobial agents, uses and compositions related thereto |
04/12/2000 | EP0991619A1 INHIBITORS OF $g(a) 4?$g(b) 1?MEDIATED CELL ADHESION |
04/12/2000 | CN1051311C N-heteroaryl-n'-phenylurea derivatives, their production and use |
04/12/2000 | CN1051303C Cyclopentadiene derivatives, its producing process and use,and lubricant or fuel oil composition and concentrate containing the same |
04/12/2000 | CN1051302C 3-(indol-3-yL) propenoic acid derivatives and as NMDA antagonists |
04/12/2000 | CN1051301C Indoloylguanidine derivatives, its pharmaceutical composition and use |
04/11/2000 | US6049428 Coating a substrate with a solution of an organic dye occurring in the lyotropic liquid-crystal state in a solvent while simultaneously orienting the dye and removing the solvent |
04/11/2000 | US6049018 As alkylation catalyst for alkylation of aromatic hydrocarbons |
04/11/2000 | US6048986 Dehydration of difluoropyromellitic acid to form difluoropyromellitic dianhydride |
04/11/2000 | US6048872 Dietetics; antidiabetic agents; cardiovascular disorders; gastrointestinal disorders |
04/11/2000 | US6048858 Heteroring containing a sulfonamide group |
04/11/2000 | US6048852 Bactericides |
04/11/2000 | US6048637 Nonaqueous secondary battery |
04/06/2000 | WO2000018767A2 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands |
04/06/2000 | WO2000018735A1 2-substituted heterocyclic sulfonamides |
04/06/2000 | WO2000018734A1 Novel substituted indolinones with an inhibitory effect on various kinases and cyclin/cdk complexes |
04/06/2000 | WO2000018733A1 Heterocyclic 2-substituted ketoamides useful for treating hair loss in mammals |
04/06/2000 | WO2000018724A1 (R)-CHIRAL HALOGENATED 1-SUBSTITUTEDAMINO-(n+1)-ALKANOLS USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
04/06/2000 | WO2000018721A1 Substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity |
04/06/2000 | WO2000018708A1 Transfer hydrogenation process |
04/06/2000 | WO1999061013A3 COMPOUNDS HAVING IgE AFFECTING PROPERTIES |
04/06/2000 | CA2345944A1 2-piperazino alkylamino benzoazole derivatives: dopamine receptor subtype specific ligands |
04/06/2000 | CA2342622A1 New substituted indolinones,their preparation and their use as medicaments |
04/05/2000 | EP0990641A1 Process for the synthesis of alpha-substituted ring systems |
04/05/2000 | EP0990637A1 Process for producing ketoprofen and 5-benzoyl-3-methyl-2-indolinone |
04/05/2000 | EP0989973A1 Chalcones having antiproliferative activity |
04/05/2000 | EP0785923B1 Dihalopropene compounds, insecticidal/acaricidal agents containing same, and intermediates for their production |
04/05/2000 | CN1249756A Metallocenes and catalysts for olefin-polymerisation |
04/05/2000 | CN1249742A Anti-inflammatory compounds |
04/04/2000 | US6046361 Polyorganofullerenes |
04/04/2000 | US6046341 An active drug having affinity for vasopressin and/or oxytocin receptors |
04/04/2000 | US6046211 Amidino derivatives useful as nitric oxide synthase inhibitors |
04/04/2000 | US6046138 For inducing root formation in a broad range of plants; efficiency |
04/04/2000 | US6045398 Battery accepting unit and battery pack |
04/04/2000 | CA2204739C Macrocyclic lactone compounds and their production process |
04/04/2000 | CA2105402C Radiolabelled compound formulations |
03/30/2000 | WO2000017182A1 PROCESS FOR OBTAINING HMG-CoA REDUCTASE INHIBITORS OF HIGH PURITY |
03/30/2000 | WO2000017162A1 Novel thiol derivatives, process for producing the same and utilization thereof |
03/30/2000 | WO2000016810A1 Near infrared fluorescent contrast agent and fluorescence imaging |
03/30/2000 | DE19844003A1 New 3-aminomethylidene-2-indolinone derivatives useful as kinase inhibitors and antiproliferative agents e.g. for treating viral infections, tumors, inflammation or autoimmune disease |
03/30/2000 | CA2413033A1 Near infrared fluorescent contrast agent and fluorescence imaging |
03/30/2000 | CA2344412A1 Thiol compound, their production and use |
03/30/2000 | CA2344315A1 Near infrared fluorescent contrast agent and fluorescence imaging |
03/30/2000 | CA2343645A1 Process for obtaining hmg-coa reductase inhibitors of high purity |
03/29/2000 | EP0989128A1 4-Hydroxyindoles kationic and their use for oxidation dyeing of keratinous fibres |
03/29/2000 | EP0989119A1 Process and intermediates for preparing trovafloxacin acid salts |
03/29/2000 | EP0988060A2 Acid-labile and enzymatically divisible dye compounds for diagnosis with near infrared light and for therapy |
03/29/2000 | EP0988057A1 Drug targeting |
03/29/2000 | EP0988035A1 Caspases and apoptosis |
03/29/2000 | EP0988034A1 Cox-2 selective carprofen for treating pain and inflammation in dogs |
03/29/2000 | EP0987997A1 N-methyl-d-aspartate (nmda) receptor blockers for the prevention of atherosclerosis |
03/29/2000 | CN1248973A Oxazolidines as 5-HT2A-antagonists |
03/29/2000 | CN1248972A Cycloimido-substituted benzofused heterocyclic herbicides |
03/29/2000 | CN1248968A Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of MIP-1-alpha binding to its CCRI receptor |
03/29/2000 | CN1248580A Process for preparing monacid salt of tonorfloxacin |
03/29/2000 | CN1248577A Novel cation type 4-oxyindole, its oxidation dyeing, dyeing composition and dyeing method for keration fibre |
03/29/2000 | CN1248435A Keratin fibre dyeing composition using cation direct dye and thickening polymer |
03/29/2000 | CN1050841C Indole derivatives and medicinal composition having same |
03/28/2000 | US6043393 By reacting carboxamides, olefins, alkylmagnesium halides or zinc alkyl compounds, and orthometallates of given formula; regioselective, fast and cost effective synthesis; useful for various bioactivities |
03/28/2000 | US6043390 Useful for the intracellular delivery of polynucleotides; cationic lipids useful in the preparation of liposomes and other lipid vesicles for the delivery of nucleic acids into mammalian cells |
03/28/2000 | US6043281 Aldose reductase inhibitors; treatment or prevention of complications of diabetes |
03/28/2000 | US6043270 Antiinflammatory agents |
03/28/2000 | US6043264 Benzene-condensed heterocyclic derivatives and their uses |
03/28/2000 | US6043257 Amidinoindoles, amidinoazoles, and analogs thereof |
03/28/2000 | US6043247 Modulators of molecules with phosphotyrosine recognition units |
03/28/2000 | US6043233 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs |
03/28/2000 | US6043232 Nitroso esters of beta-oxo-amides and aryl propionic acid derivatives of non-steroidal antiinflammatory drugs |
03/28/2000 | US6042814 Sulphonic acids and their use as UV absorbers |
03/28/2000 | CA2160270C 1,2-ethanediol derivative and salt thereof, process for producing the same, and cerebral function-improving agent comprising the same |
03/23/2000 | WO2000015657A1 Piperizine-4-phenyl derivatives as inhibitors of the interaction between mdm2 and 53 |
03/23/2000 | WO2000015634A2 Hiv protease inhibitors |
03/23/2000 | WO2000015633A1 Condensed heterocylic compounds and herbicides containing them |
03/23/2000 | WO2000015612A1 Aza-bicycles which modulate the inhibition of cell adhesion |
03/23/2000 | WO2000015603A1 Benzene derivatives and medicinal use thereof |
03/23/2000 | WO2000015206A2 Tryptophanyl ester and their n-acyl derivatives for the prevention and treatment of diseases caused or exacerbated by oxidation processes |
03/23/2000 | WO1999063983A9 MULTIBINDING AGENTS THAT MODULATE PPARη AND RXR RECEPTORS |
03/23/2000 | WO1998015272A8 Method for inhibiting stress-activated protein kinases |
03/23/2000 | CA2343101A1 Benzene derivatives and medicinal use thereof |
03/23/2000 | CA2343017A1 Condensed heterocylic compounds and herbicides containing them |
03/23/2000 | CA2341677A1 Aza-bicycles which modulate the inhibition of cell adhesion |
03/23/2000 | CA2339275A1 5,6-dihydro-4-hydroxy-2-pyranones as hiv aspartyl protease inhibitors |